Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
American Journal of Respiratory and Critical Care Medicine|August 1, 1996
The relationship between wheezing and lung mechanics during methacholine-induced bronchoconstriction in asthmatic subjectsD P Spence, D R Graham, G Jamieson, et al.Infection Control : IC|January 1, 1981
Gentamicin treatment associated with later nosocomial gentamicin-resistant Serratia marcescens infectionsD R Graham, H W Clegg, R L Anderson, et al.British Journal of Hospital Medicine (London, England : 2005)|March 12, 2010
How well are graduates prepared for practice when measured against the latest GMC recommendations?J M Brown, S Watmough, M G Cherry, et al.The New England Journal of Medicine|February 18, 1999
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working GroupT L Smith, M L Pearson, K R Wilcox, et al.JAMA|March 12, 1982
Toxic shock syndrome associated with surgical wound infectionsP Bartlett, A L Reingold, D R Graham, et al.The Journal of Infectious Diseases|September 1, 1981
Epidemic nosocomial meningitis due to Citrobacter diversus in neonatesD R Graham, R L Anderson, F E Ariel, et al.The New England Journal of Medicine|December 18, 1980
Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 casesK N Shands, G P Schmid, B B Dan, et al.JAMA|August 20, 1982
Risk factors for development of toxic shock syndrome. Association with a tampon brandW F Schlech, K N Shands, A L Reingold, et al.The Journal of Antimicrobial Chemotherapy|September 3, 1999
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection GroupR L Nichols, D R Graham, S L Barriere, et al.Antimicrobial Agents and Chemotherapy|January 1, 1990
Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapyR J Wallace, G Bedsole, G Sumter, et al.Pageof 8